HEADER TRANSFERASE 08-MAY-18 6GHK TITLE HUMAN PARP1 (ARTD1) - CATALYTIC DOMAIN IN COMPLEX WITH INHIBITOR TITLE 2 ME0527 COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLY [ADP-RIBOSE] POLYMERASE 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PARP-1,ADP-RIBOSYLTRANSFERASE DIPHTHERIA TOXIN-LIKE 1,ARTD1, COMPND 5 NAD(+) ADP-RIBOSYLTRANSFERASE 1,ADPRT 1,POLY[ADP-RIBOSE] SYNTHASE 1; COMPND 6 EC: 2.4.2.30; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PARP1, ADPRT, PPOL; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INHIBITOR, ADP-RIBOSYL TRANSFERASE, PROTEIN-LIGAND COMPLEX, KEYWDS 2 TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR T.KARLBERG,A.G.THORSELL,A.E.G.LINDGREN,M.MOCHE,J.BROCK,T.EKBLAD, AUTHOR 2 S.SPJUT,M.ELOFSSON,H.SCHULER REVDAT 2 17-JAN-24 6GHK 1 REMARK REVDAT 1 22-MAY-19 6GHK 0 JRNL AUTH T.KARLBERG,A.G.THORSELL,A.E.G.LINDGREN,T.EKBLAD,S.SPJUT, JRNL AUTH 2 M.ELOFSSON,H.SCHULER JRNL TITL HUMAN PARP1 (ARTD1) - CATALYTIC DOMAIN IN COMPLEX WITH JRNL TITL 2 INHIBITOR ME0527 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.28 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.13_2998: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.28 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.85 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 39736 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.189 REMARK 3 R VALUE (WORKING SET) : 0.187 REMARK 3 FREE R VALUE : 0.227 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1986 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 48.8634 - 5.4863 1.00 2796 147 0.1714 0.1874 REMARK 3 2 5.4863 - 4.3555 1.00 2725 143 0.1391 0.1447 REMARK 3 3 4.3555 - 3.8052 1.00 2695 142 0.1473 0.1882 REMARK 3 4 3.8052 - 3.4574 1.00 2730 144 0.1722 0.1978 REMARK 3 5 3.4574 - 3.2096 1.00 2698 142 0.1931 0.2693 REMARK 3 6 3.2096 - 3.0204 1.00 2694 141 0.2051 0.2432 REMARK 3 7 3.0204 - 2.8692 1.00 2684 142 0.2053 0.2442 REMARK 3 8 2.8692 - 2.7443 1.00 2697 142 0.2127 0.2642 REMARK 3 9 2.7443 - 2.6386 1.00 2690 141 0.2294 0.2951 REMARK 3 10 2.6386 - 2.5476 1.00 2666 141 0.2275 0.2785 REMARK 3 11 2.5476 - 2.4679 1.00 2700 142 0.2304 0.3043 REMARK 3 12 2.4679 - 2.3974 1.00 2666 140 0.2313 0.3037 REMARK 3 13 2.3974 - 2.3343 1.00 2682 141 0.2365 0.2936 REMARK 3 14 2.3343 - 2.2773 0.97 2627 138 0.2445 0.3256 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.290 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.210 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 5748 REMARK 3 ANGLE : 1.130 7756 REMARK 3 CHIRALITY : 0.063 853 REMARK 3 PLANARITY : 0.006 983 REMARK 3 DIHEDRAL : 11.082 3498 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 20.2579 -6.2411 20.1888 REMARK 3 T TENSOR REMARK 3 T11: 0.1849 T22: 0.1448 REMARK 3 T33: 0.1282 T12: 0.0066 REMARK 3 T13: -0.0260 T23: -0.0092 REMARK 3 L TENSOR REMARK 3 L11: 1.6542 L22: 0.4513 REMARK 3 L33: 0.4797 L12: 0.2319 REMARK 3 L13: -0.2764 L23: -0.1530 REMARK 3 S TENSOR REMARK 3 S11: 0.0336 S12: -0.1921 S13: 0.0106 REMARK 3 S21: 0.0437 S22: -0.0355 S23: 0.0157 REMARK 3 S31: -0.0593 S32: 0.0071 S33: 0.0012 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6GHK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 08-MAY-18. REMARK 100 THE DEPOSITION ID IS D_1200009957. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-MAY-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91841 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX-225 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 39741 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.280 REMARK 200 RESOLUTION RANGE LOW (A) : 48.850 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 6.900 REMARK 200 R MERGE (I) : 0.16600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.28 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.42 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.4 REMARK 200 DATA REDUNDANCY IN SHELL : 6.90 REMARK 200 R MERGE FOR SHELL (I) : 0.83800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4GV7 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.87 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.73 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 22.5% PEG 3350, 0.18M AMMONIUM REMARK 280 SULFATE, 0.09M BIS-TRIS, PH 5.5, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 34.28200 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 783 REMARK 465 ASP A 784 REMARK 465 THR A 824 REMARK 465 THR A 825 REMARK 465 HIS A 826 REMARK 465 HIS A 1016 REMARK 465 HIS A 1017 REMARK 465 HIS A 1018 REMARK 465 ASP B 783 REMARK 465 ASP B 784 REMARK 465 HIS B 1018 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLU A 763 O HOH A 1201 2.12 REMARK 500 OD1 ASN A 868 O HOH A 1202 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 971 CB - CG - CD2 ANGL. DEV. = -10.5 DEGREES REMARK 500 LYS B 748 CG - CD - CE ANGL. DEV. = -26.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 786 -12.13 82.83 REMARK 500 ALA A 828 52.39 -91.82 REMARK 500 SER B 786 -0.92 81.92 REMARK 500 LYS B1010 140.80 -171.84 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EZ2 A 1101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 1102 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 1103 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 1104 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 1105 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EZ2 B 1101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 1102 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 1103 DBREF 6GHK A 662 1012 UNP P09874 PARP1_HUMAN 662 1012 DBREF 6GHK B 662 1012 UNP P09874 PARP1_HUMAN 662 1012 SEQADV 6GHK MET A 661 UNP P09874 INITIATING METHIONINE SEQADV 6GHK ALA A 762 UNP P09874 VAL 762 CONFLICT SEQADV 6GHK ALA A 1012 UNP P09874 SER 1012 EXPRESSION TAG SEQADV 6GHK HIS A 1013 UNP P09874 EXPRESSION TAG SEQADV 6GHK HIS A 1014 UNP P09874 EXPRESSION TAG SEQADV 6GHK HIS A 1015 UNP P09874 EXPRESSION TAG SEQADV 6GHK HIS A 1016 UNP P09874 EXPRESSION TAG SEQADV 6GHK HIS A 1017 UNP P09874 EXPRESSION TAG SEQADV 6GHK HIS A 1018 UNP P09874 EXPRESSION TAG SEQADV 6GHK MET B 661 UNP P09874 INITIATING METHIONINE SEQADV 6GHK ALA B 762 UNP P09874 VAL 762 CONFLICT SEQADV 6GHK ALA B 1012 UNP P09874 SER 1012 EXPRESSION TAG SEQADV 6GHK HIS B 1013 UNP P09874 EXPRESSION TAG SEQADV 6GHK HIS B 1014 UNP P09874 EXPRESSION TAG SEQADV 6GHK HIS B 1015 UNP P09874 EXPRESSION TAG SEQADV 6GHK HIS B 1016 UNP P09874 EXPRESSION TAG SEQADV 6GHK HIS B 1017 UNP P09874 EXPRESSION TAG SEQADV 6GHK HIS B 1018 UNP P09874 EXPRESSION TAG SEQRES 1 A 358 MET LYS SER LYS LEU PRO LYS PRO VAL GLN ASP LEU ILE SEQRES 2 A 358 LYS MET ILE PHE ASP VAL GLU SER MET LYS LYS ALA MET SEQRES 3 A 358 VAL GLU TYR GLU ILE ASP LEU GLN LYS MET PRO LEU GLY SEQRES 4 A 358 LYS LEU SER LYS ARG GLN ILE GLN ALA ALA TYR SER ILE SEQRES 5 A 358 LEU SER GLU VAL GLN GLN ALA VAL SER GLN GLY SER SER SEQRES 6 A 358 ASP SER GLN ILE LEU ASP LEU SER ASN ARG PHE TYR THR SEQRES 7 A 358 LEU ILE PRO HIS ASP PHE GLY MET LYS LYS PRO PRO LEU SEQRES 8 A 358 LEU ASN ASN ALA ASP SER VAL GLN ALA LYS ALA GLU MET SEQRES 9 A 358 LEU ASP ASN LEU LEU ASP ILE GLU VAL ALA TYR SER LEU SEQRES 10 A 358 LEU ARG GLY GLY SER ASP ASP SER SER LYS ASP PRO ILE SEQRES 11 A 358 ASP VAL ASN TYR GLU LYS LEU LYS THR ASP ILE LYS VAL SEQRES 12 A 358 VAL ASP ARG ASP SER GLU GLU ALA GLU ILE ILE ARG LYS SEQRES 13 A 358 TYR VAL LYS ASN THR HIS ALA THR THR HIS ASN ALA TYR SEQRES 14 A 358 ASP LEU GLU VAL ILE ASP ILE PHE LYS ILE GLU ARG GLU SEQRES 15 A 358 GLY GLU CYS GLN ARG TYR LYS PRO PHE LYS GLN LEU HIS SEQRES 16 A 358 ASN ARG ARG LEU LEU TRP HIS GLY SER ARG THR THR ASN SEQRES 17 A 358 PHE ALA GLY ILE LEU SER GLN GLY LEU ARG ILE ALA PRO SEQRES 18 A 358 PRO GLU ALA PRO VAL THR GLY TYR MET PHE GLY LYS GLY SEQRES 19 A 358 ILE TYR PHE ALA ASP MET VAL SER LYS SER ALA ASN TYR SEQRES 20 A 358 CYS HIS THR SER GLN GLY ASP PRO ILE GLY LEU ILE LEU SEQRES 21 A 358 LEU GLY GLU VAL ALA LEU GLY ASN MET TYR GLU LEU LYS SEQRES 22 A 358 HIS ALA SER HIS ILE SER LYS LEU PRO LYS GLY LYS HIS SEQRES 23 A 358 SER VAL LYS GLY LEU GLY LYS THR THR PRO ASP PRO SER SEQRES 24 A 358 ALA ASN ILE SER LEU ASP GLY VAL ASP VAL PRO LEU GLY SEQRES 25 A 358 THR GLY ILE SER SER GLY VAL ASN ASP THR SER LEU LEU SEQRES 26 A 358 TYR ASN GLU TYR ILE VAL TYR ASP ILE ALA GLN VAL ASN SEQRES 27 A 358 LEU LYS TYR LEU LEU LYS LEU LYS PHE ASN PHE LYS THR SEQRES 28 A 358 ALA HIS HIS HIS HIS HIS HIS SEQRES 1 B 358 MET LYS SER LYS LEU PRO LYS PRO VAL GLN ASP LEU ILE SEQRES 2 B 358 LYS MET ILE PHE ASP VAL GLU SER MET LYS LYS ALA MET SEQRES 3 B 358 VAL GLU TYR GLU ILE ASP LEU GLN LYS MET PRO LEU GLY SEQRES 4 B 358 LYS LEU SER LYS ARG GLN ILE GLN ALA ALA TYR SER ILE SEQRES 5 B 358 LEU SER GLU VAL GLN GLN ALA VAL SER GLN GLY SER SER SEQRES 6 B 358 ASP SER GLN ILE LEU ASP LEU SER ASN ARG PHE TYR THR SEQRES 7 B 358 LEU ILE PRO HIS ASP PHE GLY MET LYS LYS PRO PRO LEU SEQRES 8 B 358 LEU ASN ASN ALA ASP SER VAL GLN ALA LYS ALA GLU MET SEQRES 9 B 358 LEU ASP ASN LEU LEU ASP ILE GLU VAL ALA TYR SER LEU SEQRES 10 B 358 LEU ARG GLY GLY SER ASP ASP SER SER LYS ASP PRO ILE SEQRES 11 B 358 ASP VAL ASN TYR GLU LYS LEU LYS THR ASP ILE LYS VAL SEQRES 12 B 358 VAL ASP ARG ASP SER GLU GLU ALA GLU ILE ILE ARG LYS SEQRES 13 B 358 TYR VAL LYS ASN THR HIS ALA THR THR HIS ASN ALA TYR SEQRES 14 B 358 ASP LEU GLU VAL ILE ASP ILE PHE LYS ILE GLU ARG GLU SEQRES 15 B 358 GLY GLU CYS GLN ARG TYR LYS PRO PHE LYS GLN LEU HIS SEQRES 16 B 358 ASN ARG ARG LEU LEU TRP HIS GLY SER ARG THR THR ASN SEQRES 17 B 358 PHE ALA GLY ILE LEU SER GLN GLY LEU ARG ILE ALA PRO SEQRES 18 B 358 PRO GLU ALA PRO VAL THR GLY TYR MET PHE GLY LYS GLY SEQRES 19 B 358 ILE TYR PHE ALA ASP MET VAL SER LYS SER ALA ASN TYR SEQRES 20 B 358 CYS HIS THR SER GLN GLY ASP PRO ILE GLY LEU ILE LEU SEQRES 21 B 358 LEU GLY GLU VAL ALA LEU GLY ASN MET TYR GLU LEU LYS SEQRES 22 B 358 HIS ALA SER HIS ILE SER LYS LEU PRO LYS GLY LYS HIS SEQRES 23 B 358 SER VAL LYS GLY LEU GLY LYS THR THR PRO ASP PRO SER SEQRES 24 B 358 ALA ASN ILE SER LEU ASP GLY VAL ASP VAL PRO LEU GLY SEQRES 25 B 358 THR GLY ILE SER SER GLY VAL ASN ASP THR SER LEU LEU SEQRES 26 B 358 TYR ASN GLU TYR ILE VAL TYR ASP ILE ALA GLN VAL ASN SEQRES 27 B 358 LEU LYS TYR LEU LEU LYS LEU LYS PHE ASN PHE LYS THR SEQRES 28 B 358 ALA HIS HIS HIS HIS HIS HIS HET EZ2 A1101 29 HET SO4 A1102 5 HET SO4 A1103 5 HET SO4 A1104 5 HET SO4 A1105 5 HET EZ2 B1101 29 HET SO4 B1102 5 HET SO4 B1103 5 HETNAM EZ2 ~{N}-[(1~{R})-1-(4-IMIDAZOL-1-YLPHENYL)ETHYL]-3-(4- HETNAM 2 EZ2 OXIDANYLIDENE-1~{H}-QUINAZOLIN-2-YL)PROPANAMIDE HETNAM SO4 SULFATE ION FORMUL 3 EZ2 2(C22 H21 N5 O2) FORMUL 4 SO4 6(O4 S 2-) FORMUL 11 HOH *208(H2 O) HELIX 1 AA1 PRO A 666 PHE A 677 1 12 HELIX 2 AA2 ASP A 678 TYR A 689 1 12 HELIX 3 AA3 PRO A 697 LEU A 701 5 5 HELIX 4 AA4 SER A 702 GLN A 722 1 21 HELIX 5 AA5 SER A 725 ILE A 740 1 16 HELIX 6 AA6 ASN A 754 GLY A 780 1 27 HELIX 7 AA7 ASP A 788 LEU A 797 1 10 HELIX 8 AA8 SER A 808 THR A 821 1 14 HELIX 9 AA9 GLY A 843 GLN A 853 1 11 HELIX 10 AB1 ARG A 865 THR A 867 5 3 HELIX 11 AB2 ASN A 868 GLY A 876 1 9 HELIX 12 AB3 PRO A 885 TYR A 889 5 5 HELIX 13 AB4 MET A 900 ASN A 906 1 7 HELIX 14 AB5 PRO A 958 ASN A 961 5 4 HELIX 15 AB6 ASP A 993 ALA A 995 5 3 HELIX 16 AB7 PRO B 666 PHE B 677 1 12 HELIX 17 AB8 ASP B 678 TYR B 689 1 12 HELIX 18 AB9 PRO B 697 LEU B 701 5 5 HELIX 19 AC1 SER B 702 GLN B 722 1 21 HELIX 20 AC2 SER B 725 ILE B 740 1 16 HELIX 21 AC3 ASN B 754 GLY B 780 1 27 HELIX 22 AC4 ASP B 788 LEU B 797 1 10 HELIX 23 AC5 SER B 808 THR B 821 1 14 HELIX 24 AC6 GLY B 843 LYS B 849 1 7 HELIX 25 AC7 PRO B 850 LEU B 854 5 5 HELIX 26 AC8 ARG B 865 THR B 867 5 3 HELIX 27 AC9 ASN B 868 GLY B 876 1 9 HELIX 28 AD1 PRO B 885 TYR B 889 5 5 HELIX 29 AD2 MET B 900 ASN B 906 1 7 HELIX 30 AD3 PRO B 958 ASN B 961 5 4 HELIX 31 AD4 ASP B 993 ALA B 995 5 3 SHEET 1 AA1 5 THR A 799 VAL A 803 0 SHEET 2 AA1 5 TYR A 829 ARG A 841 -1 O LYS A 838 N LYS A 802 SHEET 3 AA1 5 VAL A 997 PHE A1009 -1 O LYS A1006 N GLU A 832 SHEET 4 AA1 5 ILE A 916 ALA A 925 -1 N ILE A 919 O LEU A1003 SHEET 5 AA1 5 ARG A 857 SER A 864 -1 N LEU A 860 O GLY A 922 SHEET 1 AA2 4 ILE A 895 PHE A 897 0 SHEET 2 AA2 4 GLU A 988 VAL A 991 -1 O VAL A 991 N ILE A 895 SHEET 3 AA2 4 SER A 947 GLY A 950 -1 N GLY A 950 O GLU A 988 SHEET 4 AA2 4 MET A 929 LEU A 932 1 N TYR A 930 O SER A 947 SHEET 1 AA3 3 GLY A 974 SER A 976 0 SHEET 2 AA3 3 GLY A 952 PRO A 956 -1 N THR A 955 O ILE A 975 SHEET 3 AA3 3 LEU A 984 TYR A 986 1 O LEU A 985 N THR A 954 SHEET 1 AA4 2 ILE A 962 LEU A 964 0 SHEET 2 AA4 2 VAL A 967 VAL A 969 -1 O VAL A 969 N ILE A 962 SHEET 1 AA5 5 THR B 799 VAL B 803 0 SHEET 2 AA5 5 TYR B 829 ARG B 841 -1 O LYS B 838 N LYS B 802 SHEET 3 AA5 5 VAL B 997 PHE B1009 -1 O LYS B1006 N GLU B 832 SHEET 4 AA5 5 ILE B 916 ALA B 925 -1 N ILE B 919 O LEU B1003 SHEET 5 AA5 5 ARG B 857 SER B 864 -1 N ARG B 858 O VAL B 924 SHEET 1 AA6 4 ILE B 895 PHE B 897 0 SHEET 2 AA6 4 GLU B 988 VAL B 991 -1 O VAL B 991 N ILE B 895 SHEET 3 AA6 4 SER B 947 GLY B 950 -1 N GLY B 950 O GLU B 988 SHEET 4 AA6 4 MET B 929 LEU B 932 1 N TYR B 930 O SER B 947 SHEET 1 AA7 3 GLY B 974 SER B 976 0 SHEET 2 AA7 3 GLY B 952 PRO B 956 -1 N THR B 955 O ILE B 975 SHEET 3 AA7 3 LEU B 984 TYR B 986 1 O LEU B 985 N THR B 954 SHEET 1 AA8 2 ILE B 962 LEU B 964 0 SHEET 2 AA8 2 VAL B 967 VAL B 969 -1 O VAL B 969 N ILE B 962 SITE 1 AC1 18 TYR A 710 ASP A 766 LEU A 769 HIS A 862 SITE 2 AC1 18 GLY A 863 ARG A 878 ILE A 879 ALA A 880 SITE 3 AC1 18 TYR A 889 GLY A 894 TYR A 896 PHE A 897 SITE 4 AC1 18 SER A 904 TYR A 907 GLU A 988 HOH A1211 SITE 5 AC1 18 HOH A1274 HOH A1281 SITE 1 AC2 7 SER A 702 LYS A 703 ARG A 704 HOH A1258 SITE 2 AC2 7 HOH A1294 LYS B 798 GLN B 875 SITE 1 AC3 7 ARG A 865 ASN A 906 HIS A 909 HOH A1206 SITE 2 AC3 7 HOH A1224 ALA B1012 HIS B1013 SITE 1 AC4 7 ALA A1012 HIS A1013 HOH A1239 ARG B 865 SITE 2 AC4 7 ASN B 906 HIS B 909 HOH B1222 SITE 1 AC5 7 LYS A 903 LEU A 984 LEU A 985 TYR A 986 SITE 2 AC5 7 HOH A1223 HIS B1014 HIS B1016 SITE 1 AC6 17 TYR B 710 ASP B 766 HIS B 862 GLY B 863 SITE 2 AC6 17 ARG B 878 ALA B 880 PRO B 881 TYR B 889 SITE 3 AC6 17 GLY B 894 TYR B 896 PHE B 897 SER B 904 SITE 4 AC6 17 TYR B 907 GLU B 988 HOH B1242 HOH B1251 SITE 5 AC6 17 HOH B1263 SITE 1 AC7 6 LYS A 798 GLN A 875 SER B 702 LYS B 703 SITE 2 AC7 6 ARG B 704 HOH B1236 SITE 1 AC8 7 HIS A1014 LYS B 903 LEU B 984 LEU B 985 SITE 2 AC8 7 TYR B 986 HOH B1208 HOH B1216 CRYST1 74.550 68.564 91.813 90.00 110.95 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013414 0.000000 0.005135 0.00000 SCALE2 0.000000 0.014585 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011662 0.00000